|1.||Gill, Parkash S: 11 articles (01/2015 - 06/2005)|
|2.||Krasnoperov, Valery: 9 articles (01/2014 - 06/2005)|
|3.||Liu, Ren: 8 articles (01/2015 - 04/2010)|
|4.||Stephenson, Sally-Anne: 5 articles (04/2015 - 01/2005)|
|5.||Pasquale, Elena B: 5 articles (01/2011 - 08/2006)|
|6.||Matsuo, Koichi: 4 articles (09/2015 - 05/2009)|
|7.||Herington, Adrian C: 4 articles (04/2015 - 09/2012)|
|8.||Mertens-Walker, Inga: 4 articles (04/2015 - 09/2012)|
|9.||Kumar, S Ram: 4 articles (01/2014 - 06/2005)|
|10.||Lisle, Jessica E: 3 articles (04/2015 - 09/2012)|
11/01/2015 - "Specific photothermal therapy to the tumors with high EphB4 receptor expression."
04/10/2015 - "Addition of antibody to cancer cells resulted in phosphorylation and subsequent degradation of the EphB4 protein, suggesting a mechanism that is ligand mimetic and tumour suppressive. "
05/01/2014 - "We have previously shown that epithelial overexpression of the EphB4 receptor results in defective mammary epithelial development and conferred a metastasizing tumor phenotype on experimental mouse mammary tumors accompanied by a preponderance of progenitor cells. "
02/01/2013 - "In conclusion, EphB4 receptor maybe a promising targeted goal of antiangiogenic formation, which provides a new approach and method for tumor treatment."
02/01/2013 - "EphB4 receptor is correlated to the initiation, progression and tumor angiogenesis. "
|2.||Pancreatic Neoplasms (Pancreatic Cancer)
|3.||Ovarian Neoplasms (Ovarian Cancer)
02/01/2003 - "Strikingly, we observed a drastic increase (P <0.0001) in the number of EphB4 protein-expressing glandular epithelial cells in the majority of hyperplasias and carcinomas. "
09/01/2002 - "Strikingly, a drastic reduction in the number of EphB4 protein expressing cells was observed in almost all invasive carcinomas analyzed, irrespective of the tumor type (p<0.0001). "
08/01/2007 - "The prognostic importance of ephrin-B2 ligand (EFNB2) and its receptor EphB4, and its correlation with clinicopathologic characteristics are yet to be delineated in patients with oesophageal carcinoma. "
01/01/2005 - "Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma."
|5.||Prostatic Neoplasms (Prostate Cancer)
06/01/2005 - "EphB4 protein levels are high in the PC3 prostate cancer cell line and several folds higher in a metastatic clone of PC3 (PC3M) where overexpression was accompanied by EphB4 gene amplification. "
06/01/2005 - "Knockdown of the EphB4 protein using EphB4 short interfering RNA or antisense oligodeoxynucleotide significantly inhibits cell growth/viability, migration, and invasion, and induces apoptosis in prostate cancer cell lines. "
01/01/2005 - "The EphB4 receptor tyrosine kinase has been reported as increased in tumours originating from several different tissues and its expression in a prostate cancer xenograft model has been reported. "
01/01/2015 - "The EphB4 receptor tyrosine kinase is overexpressed in many cancers including prostate cancer. "
|2.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|3.||Ephrin-B2 (Ephrin B2)
|5.||Messenger RNA (mRNA)
|6.||tyrosine receptor (receptor, tyrosine)
|7.||Eph Family Receptors (Eph Receptors)
|8.||Small Interfering RNA (siRNA)
|10.||RNA-Directed DNA Polymerase (Reverse Transcriptase)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)